Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies. - Izgutdina A; Rashid T; Temple WC; Aminov S; Patiño-Escobar B; Walunj S; Geng H; Takamatsu H; Gil-Alós D; Kang AS; Ramos E; Chen SY; et al. (Journal for immunotherapy of cancer, 2025)